Cashu | News | SRPT

HomeWatchlistNewsSignalsPicks

DJI

+0.39%

SPX

+0.27%

IXIC

+0.18%

FTSE

+0.12%

N225

-0.22%

AXJO

-0.21%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Sarepta Therapeutics News

Dow Surges Over 300 Points As Iran Signals De-Escalation: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Feature Image for interests on Cnn Business Fear & Greed Index, Consumer Cyclical, Healthcare, Iran from benzinga.com

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

Feature Image for interests on Consumer Cyclical, Consumer Defensive, ETF, Energy from cnbc.com

Sarepta Crashes After Second Death On Gene Therapy Drug

Feature Image for interests on ETF, Financial Services, Healthcare, Stock from zerohedge.com

What the Options Market Tells Us About Sarepta Therapeutics

Stocks making the biggest moves midday: Meta Platforms, AMD, Cisco, Roku, MGM Resorts and more

Feature Image for interests on Breaking News: Economy, Breaking News: Markets, Communication Services, Consumer Cyclical from cnbc.com

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Feature Image for interests on Big Losers, Healthcare, Markets, News from benzinga.com

Stocks making the biggest moves premarket: U.S. Steel, Roku, Celsius, Sarepta Therapeutics and more

Feature Image for interests on Breaking News: Economy, Breaking News: Markets, Communication Services, Consumer Cyclical from cnbc.com

Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy

Feature Image for interests on Biotech, Briefs, Healthcare, News from benzinga.com

Sarepta Therapeutics Stock: A Deep Dive Into Analyst Perspectives (28 Ratings)

Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com

Stocks

Health Care

srpt

Sarepta Therapeutics

SRPT

-0.34 (-1.66%)

20.425

USD

At close at Jun 20, 14:08 UTC

Latest Cashu News

Sarepta Therapeutics Advances Gene Therapy for Rare Diseases, Especially Duchenne Muscular Dystrophy

about 17 hours ago

Sarepta Therapeutics Confronts Safety Crisis with Elevidys Gene Therapy Amid Patient Deaths

Sarepta Therapeutics Faces Stock Plunge Amid Safety Concerns for Elevidys Gene Therapy